857 / 1631
DLBCL is a curable disease
Cunningham, J Clin Oncol (2009) 27:15s,
150 1080
Events Totals
PATIENTS at Risk
1080 834 621 434 278 134 61
8
0
0.0
0.2
0.4
0.6
0.8
1.0
Months from randomisation
0
6
12 18 24 30 36 42 48
2-year OS: 81%
(95% CI: 78%-84%)
Overall survival: UK R-CHOP 14 vs 21